The Motley Fool

Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Here's Why That's a Smart Move.

Vertex Pharmaceuticals will soon try to commercialize another medicine. The new therapy targets the same market as four of its other products. Using a priority review voucher is an expensive choice, ...
Verdict on MSN

GitLab, Google Cloud expand integration with Vertex AI for DevSecOps

GitLab Duo Agent Platform’s integration with Vertex AI gives enterprises governed AI model access on existing Google Cloud ...

Vertex Pharmaceuticals (VRTX) Valuation Check After FDA Expands ALYFTREK And TRIKAFTA Use

Vertex Pharmaceuticals (VRTX) is back in focus after the U.S. Food and Drug Administration expanded use of its cystic ...
GlobalData on MSN

Halozyme and Vertex sign deal for Hypercon technology

Under the agreement, Vertex will make a $15m upfront payment to Halozyme and potential future milestone payments.
The Boston Globe

Vertex falls after FDA doubts broad use of chronic pain drug

Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators said they didn’t see a path forward for broad use of its pill in treating a ...
FierceBiotech

Vertex files FDA approval ask for next-gen cystic fibrosis candidate, resumes diabetes cell therapy trial

Vertex Pharmaceuticals is ahead of schedule, filing a new drug application for its next-gen cystic fibrosis (CF) treatment dubbed vanza triple. Vertex completed the regulatory submission a month ...
Seeking Alpha

Vertex And CRISPR Therapeutics - Partners On Exa-cel - But Unequally Valued

Switzerland-based CRISPR Therapeutics (CRSP) and Boston, Massachusetts-based Vertex (VRTX) have been collaborating together since signing an initial agreement in 2015, with Vertex paying CRISPR $75m ...
Investopedia

Vertex Stock in Focus After Deal to Buy Alpine Immune For $4.9B—Key Level to Watch

Deal Values Each Alpine Share at a 38% Premium to Wednesday’s Closing Price Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Vertex shares ...
Nasdaq

Vertex, Inc. Reports Q4 2024 Financial Results with 15.2% Revenue Growth and Strategic Investments for Future Growth

Total revenues of $666.8 million for the full year 2024, representing a 16.5% year-over-year increase, indicating strong business growth. Cloud revenues grew by 28.6% year-over-year for the full year ...
Seeking Alpha

Vertex Pharmaceuticals: A Full Pipeline

Vertex Pharmaceuticals released data validating the efficacy and safety of their NaV1.8 inhibitor for chronic neuropathic pain. VX-548 is a potential blockbuster for the treatment of pain and could ...

GitLab Collaborates with Google Cloud to Bring Agentic DevSecOps to Enterprise Teams Using Vertex AI

GitLab Inc., the intelligent orchestration platform for DevSecOps, today announced an expanded collaboration with Google ...
TechCrunch

Google’s generative AI support in Vertex AI is now generally available

Google announced today that its generative AI support in Vertex AI, the company’s machine learning platform, is now generally available. Based on Google’s models like PaLM 2, Imagen and Codey, Vertex ...